Artimplant builds team ahead of first CE marking
This article was originally published in Clinica
Artimplant, a publicly-quoted Swedish orthopaedic company, is ramping up its sales force in anticipation of the CE marking of its first product, a biodegradeable anterior cruciate ligament implant, expected in May.
You may also be interested in...
The first data readout for remdesivir, the much anticipated antiviral for the coronavirus pandemic, is expected in days. Scrip surveys antiviral development and regulatory experts to gauge their interest and the key aspects to watch for in the milestone announcement.
The UK has an “excellent but small diagnostics industry,” so it needs further testing support from related life science industries to tackle the COVID-19 crisis. One of the outcomes of this could be the creation of new big diagnostics industry players.